- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 02.12.24 | Novartis wagers billions of dollars on PTC Huntington's drug | ||
| 02.12.24 | Applied's rare disease drug rejected by FDA | ||
| 02.12.24 | Are You Using Next-Gen Sequencing to inform AAV product and process quality? Here are 4 reasons you should | ||
| 27.11.24 | Sarepta rebuilds drug pipeline with Arrowhead deal | ||
| 27.11.24 | How Intra-Cellular surprised Wall Street by breaking character | ||
| 27.11.24 | Kronos, Idorsia plan layoffs; PTC shelves ALS drug | ||
| 26.11.24 | Biden administration proposes Medicare, Medicaid coverage of pricey weight loss drugs | ||
| 26.11.24 | Amgen obesity drug cuts weight in study, but results miss Wall Street's high mark | ||
| 26.11.24 | Roche's TIGIT-targeting drug for cancer fails its biggest test | ||
| 26.11.24 | Roche to buy cell therapy developer Poseida for $1B | ||
| 26.11.24 | Alector turns to layoffs as Alzheimer's drug fails | ||
| 25.11.24 | New data could help Merck expand use of cardiovascular drug | ||
| 25.11.24 | Biohaven muscle drug misses goal of SMA study, but advances in obesity | ||
| 22.11.24 | Halozyme drops Evotec buyout bid; Patient dies in Neurogene trial | ||
| 22.11.24 | Lexicon to disband sales team, lay off 60% of staff | ||
| 22.11.24 | Will Walgreens' store closures disrupt its clinical trial aims? | ||
| 21.11.24 | Biotech startups are built on venture capital. Track funding rounds here. | ||
| 21.11.24 | Novartis wagers more than $1B on gene therapies for the nervous system | ||
| 21.11.24 | Amgen picks prolific biotech founder Chang as new top scientist | ||
| 21.11.24 | Versant startup sets out to make a new type of obesity drug | ||
| 20.11.24 | Sage's string of research failures continues | ||
| 20.11.24 | Pfizer, under pressure to change, names oncology head as new R&D chief | ||
| 20.11.24 | What might a Trump administration mean for the Biosecure Act? | ||
| 20.11.24 | Chasing new 'checkpoints,' startup Valora emerges from a Nobel winner's lab | ||
| 20.11.24 | Flagship, Pfizer alliance yields two more startup deals |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
